• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偶发性肾细胞癌的预后意义

Prognostic significance of incidental renal cell carcinoma.

作者信息

Bretheau D, Lechevallier E, Eghazarian C, Grisoni V, Coulange C

机构信息

Department of Urology, Salvator Hospital, Marseille, France.

出版信息

Eur Urol. 1995;27(4):319-23. doi: 10.1159/000475189.

DOI:10.1159/000475189
PMID:7656910
Abstract

From 1980 to 1991, 236 patients with renal cell carcinoma were treated in our department. We studied the characteristics and the prognostic significance of 74 patients with incidental renal cancer in comparison with those with symptomatic tumors. The mean age of the patients was 59.8 years and the sex ratio 2 males/1 female. The incidence of incidental tumors increased from 14% in 1980 to 48% in 1991. Incidental tumors were discovered mainly during examination for cardiovascular diseases (26%), hepatobiliary diseases (22%) and general health examination (23%). Local tumoral stage and histologic grade were significantly lower for the incidental tumors than for symptomatic ones (p = 0.002 and p = 0.001). In the same way, the rates of the patients with metastases or nodal involvement were lower for those with incidental tumors than for those with symptomatic tumors (p = 0.008 and p = 0.001). The mean tumoral size was 5.7 +/- 3 cm for incidental tumors and 7.6 +/- 3.5 cm for symptomatic tumors (p = 0.0001). The survival was significantly different according to the circumstances of detection of the tumors (p < 0.001); the 5- and 10-year actuarial survival rates was 85% for the patients with incidental tumors and respectively 61 and 44% for the patients with symptomatic tumors. The multivariate analysis by Cox proportional hazard model showed three important and independent prognostic factors: the presence of metastases (relative risk (RR): 6.7), nodal involvement (RR: 4.6) and symptomatic tumors (RR: 1.7). The patients with incidental tumors had a better prognosis than those with symptomatic tumors because of lower tumoral size and local stage. The early diagnosis of renal cell carcinoma improved the prognosis of the patients.

摘要

1980年至1991年期间,我科共收治236例肾细胞癌患者。我们研究了74例偶然发现的肾癌患者的特征及其预后意义,并与有症状的肿瘤患者进行了比较。患者的平均年龄为59.8岁,男女比例为2∶1。偶然发现的肿瘤发生率从1980年的14%上升至1991年的48%。偶然发现的肿瘤主要在心血管疾病检查(26%)、肝胆疾病检查(22%)及全身健康检查(23%)过程中被发现。偶然发现的肿瘤的局部肿瘤分期和组织学分级显著低于有症状的肿瘤(p = 0.002和p = 0.001)。同样,偶然发现肿瘤的患者发生转移或淋巴结受累的比例低于有症状肿瘤的患者(p = 0.008和p = 0.001)。偶然发现的肿瘤的平均肿瘤大小为5.7±3 cm,有症状肿瘤的平均肿瘤大小为7.6±3.5 cm(p = 0.0001)。根据肿瘤的发现情况,患者的生存率有显著差异(p < 0.001);偶然发现肿瘤的患者5年和10年精算生存率分别为85%,有症状肿瘤的患者5年和10年精算生存率分别为61%和44%。Cox比例风险模型的多因素分析显示,有三个重要且独立的预后因素:转移的存在(相对风险(RR):6.7)、淋巴结受累(RR:4.6)和有症状的肿瘤(RR:1.7)。由于肿瘤大小和局部分期较低,偶然发现肿瘤的患者比有症状肿瘤的患者预后更好。肾细胞癌的早期诊断改善了患者的预后。

相似文献

1
Prognostic significance of incidental renal cell carcinoma.偶发性肾细胞癌的预后意义
Eur Urol. 1995;27(4):319-23. doi: 10.1159/000475189.
2
Renal cell carcinoma: prognostic significance of incidentally detected tumors.肾细胞癌:偶然发现肿瘤的预后意义。
J Urol. 2000 Feb;163(2):426-30. doi: 10.1016/s0022-5347(05)67892-5.
3
Incidental detection of renal cell carcinoma is an independent prognostic marker: results of a long-term, whole population study.偶然发现的肾细胞癌是一个独立的预后标志物:一项长期的、全人群研究的结果。
J Urol. 2012 Jan;187(1):48-53. doi: 10.1016/j.juro.2011.09.025. Epub 2011 Nov 16.
4
Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma.肾细胞癌预后预测中超出病理因素的偶然发现。
Eur Urol. 2003 Jun;43(6):663-9. doi: 10.1016/s0302-2838(03)00142-8.
5
Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients.偶然发现对肾细胞癌患者生存的影响:基于701例患者的人群研究结果
Urology. 2005 Dec;66(6):1186-91. doi: 10.1016/j.urology.2005.07.009.
6
Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.肿瘤相关症状对肾细胞癌患者预后的影响。
Scand J Urol Nephrol. 2008;42(5):406-11. doi: 10.1080/00365590802022151.
7
Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.乳头状(嗜色性)肾细胞癌:62例的组织形态学特征及传统病理预后参数评估
Am J Surg Pathol. 1997 Jun;21(6):621-35. doi: 10.1097/00000478-199706000-00001.
8
Incidental renal neoplasms: is there a need for routine screening? A Danish single-center epidemiological study.偶发性肾肿瘤:是否需要进行常规筛查?一项丹麦单中心流行病学研究。
APMIS. 2014 Aug;122(8):708-14. doi: 10.1111/apm.12282. Epub 2014 Jun 7.
9
[Clinical study on incidental renal cell carcinoma].
Hinyokika Kiyo. 1995 Feb;41(2):93-9.
10
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.在多变量环境中,pNx/pN0分组对透明细胞肾细胞癌患者预后建模的影响。
J Urol. 2002 Jul;168(1):56-60.

引用本文的文献

1
Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis.过去四十年美国膀胱移行细胞癌的发病率和死亡率趋势:一项基于 SEER 的分析。
BMC Cancer. 2019 Jan 10;19(1):46. doi: 10.1186/s12885-019-5267-3.
2
Incidental vs symptomatic renal tumours: Survival outcomes.偶发性与症状性肾肿瘤:生存结果
Arab J Urol. 2011 Mar;9(1):17-21. doi: 10.1016/j.aju.2011.03.006. Epub 2011 May 6.
3
Associations between presenting symptoms, clinicopathological parameters, and prognosis in a contemporary series of patients with renal cell carcinoma.
当代肾癌患者系列中首发症状、临床病理参数与预后之间的关联。
Korean J Urol. 2014 Aug;55(8):505-10. doi: 10.4111/kju.2014.55.8.505. Epub 2014 Aug 8.
4
Incidence trends of urinary bladder and kidney cancers in urban Shanghai, 1973-2005.1973-2005 年上海市市区膀胱癌和肾癌发病趋势。
PLoS One. 2013 Dec 4;8(12):e82430. doi: 10.1371/journal.pone.0082430. eCollection 2013.
5
Robotic-assisted transperitoneal nephron-sparing surgery for small renal masses with associated surgical procedures: surgical technique and preliminary experience.机器人辅助经腹腔肾部分切除术治疗伴有相关手术的小肾肿瘤:手术技术及初步经验。
Updates Surg. 2013 Sep;65(3):183-90. doi: 10.1007/s13304-013-0209-0. Epub 2013 Apr 26.
6
Pazopanib for the first-line treatment of patients with advanced and/or metastatic renal cell carcinoma : a NICE single technology appraisal.帕唑帕尼作为晚期和/或转移性肾细胞癌一线治疗药物的疗效:一项 NICE 单技术评估。
Pharmacoeconomics. 2013 Jan;31(1):15-24. doi: 10.1007/s40273-012-0006-5.
7
Diabetes and risk of renal cell carcinoma.糖尿病与肾细胞癌风险
J Cancer. 2012;3:42-8. doi: 10.7150/jca.3718. Epub 2011 Dec 24.
8
A commentary on "risk factors for renal cell cancer in a Japanese population".关于“日本人群肾细胞癌的危险因素”的一篇评论
Clin Med Oncol. 2009 Aug 14;3:87-90. doi: 10.4137/cmo.s2926.
9
Renal cell carcinoma: Impact of mode of detection on its pathological characteristics.肾细胞癌:检测方式对其病理特征的影响。
Indian J Urol. 2009 Oct-Dec;25(4):479-82. doi: 10.4103/0970-1591.57919.
10
Disparities in the treatment of patients with IL-2 for metastatic renal cell carcinoma.转移性肾细胞癌患者接受白细胞介素-2 治疗的差异。
Urol Oncol. 2010 May-Jun;28(3):308-13. doi: 10.1016/j.urolonc.2008.09.022. Epub 2008 Dec 12.